Fragility Index as a Measure of Randomized Clinical Trial Quality in Adult Reconstruction: A Systematic Review

Background: The Fragility Index (FI) and Reverse Fragility Index are powerful tools to supplement the P value in evaluation of randomized clinical trial (RCT) outcomes. These metrics are defined as the number of patients needed to change the significance level of an outcome. The purpose of this stud...

Full description

Saved in:
Bibliographic Details
Main Authors: Carl L. Herndon, MD, Kyle L. McCormick, MD, Anastasia Gazgalis, MD, Elise C. Bixby, MD, Matthew M. Levitsky, MD, Alexander L. Neuwirth, MD
Format: article
Language:EN
Published: Elsevier 2021
Subjects:
Online Access:https://doaj.org/article/67f1a271d1ca4f5c8c7b007a29d3248e
Tags: Add Tag
No Tags, Be the first to tag this record!